Lv11
10 积分 2023-08-11 加入
A review of structural transformations and properties changes in starch during thermal processing of foods
3小时前
待确认
Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non-Small Cell Lung Cancer Patients
1年前
已完结
Immune-checkpoint inhibitor use in patients with cancer and pre-existing autoimmune diseases
1年前
已完结
Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study
1年前
已完结
Interim survival analysis of the randomized phase III GEMSTONE-302 trial: sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLC
1年前
已完结
Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities
1年前
已完结
Camrelizumab Plus Carboplatin and Pemetrexed as First-Line Treatment for Advanced Nonsquamous NSCLC: Extended Follow-Up of CameL Phase 3 Trial
1年前
已完结
Interim survival analysis of the randomized phase III GEMSTONE-302 trial: sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLC
1年前
已完结
Three-year follow-up and patient-reported outcomes from CheckMate 078: Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer
1年前
已完结
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy
1年前
已完结
皖公网安备34019202002308
